SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001095811-01-501311
Filing Date
2001-04-17
Accepted
2001-04-17 00:00:00
Documents
1
Period of Report
2001-05-18

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT a71629ddef14a.txt DEF 14A 247528
  Complete submission text file 0001095811-01-501311.txt   248998
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 6194526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24274 | Film No.: 1604344
SIC: 2836 Biological Products, (No Diagnostic Substances)